Post-approval studies (Phase 4)Study completedNCT01052831
What this trial is testing
Naltrexone for Impulse Control Disorders in Parkinson's Disease
Who this might be right for
Impulse Control DisorderParkinson Disease
University of Pennsylvania 50
Showing 20 of 32 results